307 related articles for article (PubMed ID: 25906442)
1. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.
Higashi M; Yokoyama S; Yamamoto T; Goto Y; Kitazono I; Hiraki T; Taguchi H; Hashimoto S; Fukukura Y; Koriyama C; Mataki Y; Maemura K; Shinchi H; Jain M; Batra SK; Yonezawa S
Pancreas; 2015 Jul; 44(5):728-34. PubMed ID: 25906442
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
Sierzega M; Młynarski D; Tomaszewska R; Kulig J
Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
5. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
6. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
[TBL] [Abstract][Full Text] [Related]
8. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
[TBL] [Abstract][Full Text] [Related]
9. Jagged1 and DLL4 expressions in benign and malignant pancreatic lesions and their clinicopathological significance.
Huang SF; Yang ZL; Li DQ; Liu ZY; Wang CW; Miao XY; Zou Q; Yuan Y
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):640-646. PubMed ID: 27919854
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
Sopha SC; Gopal P; Merchant NB; Revetta FL; Gold DV; Washington K; Shi C
Int J Clin Exp Pathol; 2013; 6(11):2476-86. PubMed ID: 24228110
[TBL] [Abstract][Full Text] [Related]
11. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
[TBL] [Abstract][Full Text] [Related]
12. Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.
Yamada R; Mizuno S; Uchida K; Yoneda M; Kanayama K; Inoue H; Murata Y; Kuriyama N; Kishiwada M; Usui M; Ii N; Tsuboi J; Tano S; Hamada Y; Tanaka K; Horiki N; Ogura T; Shiraishi T; Takei Y; Katayama N; Isaji S
Pancreas; 2016; 45(5):761-71. PubMed ID: 26784908
[TBL] [Abstract][Full Text] [Related]
13. Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.
Carrara S; Cangi MG; Arcidiacono PG; Perri F; Petrone MC; Mezzi G; Boemo C; Talarico A; Cin ED; Grassini G; Doglioni C; Testoni PA
Am J Gastroenterol; 2011 Jul; 106(7):1359-63. PubMed ID: 21647207
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis.
Gao HL; Liu L; Qi ZH; Xu HX; Wang WQ; Wu CT; Zhang SR; Xu JZ; Ni QX; Yu XJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):95-100. PubMed ID: 29576277
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
O'Connor K; Li-Chang HH; Kalloger SE; Peixoto RD; Webber DL; Owen DA; Driman DK; Kirsch R; Serra S; Scudamore CH; Renouf DJ; Schaeffer DF
Am J Surg Pathol; 2015 Apr; 39(4):472-8. PubMed ID: 25634751
[TBL] [Abstract][Full Text] [Related]
16. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
Kamphues C; Bova R; Bahra M; Klauschen F; Muckenhuber A; Sinn BV; Warth A; Goeppert B; Endris V; Neuhaus P; Weichert W; Stenzinger A
Pancreas; 2015 Mar; 44(2):296-301. PubMed ID: 25423555
[TBL] [Abstract][Full Text] [Related]
18. Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.
Bournet B; Gayral M; Torrisani J; Selves J; Cordelier P; Buscail L
World J Gastroenterol; 2014 Aug; 20(31):10758-68. PubMed ID: 25152579
[TBL] [Abstract][Full Text] [Related]
19. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
20. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.
Shibahara H; Higashi M; Koriyama C; Yokoyama S; Kitazono I; Kurumiya Y; Narita M; Kuze S; Kyokane T; Mita S; Arai T; Kato T; Yuasa N; Yamaguchi R; Kubota H; Suzuki H; Baba S; Rousseau K; Batra SK; Yonezawa S
PLoS One; 2014; 9(4):e86111. PubMed ID: 24722639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]